Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells
Nature Medicine2005Vol. 11(11), pp. 1238–1243
Citations Over TimeTop 1% of 2005 papers
Hua Zhang, Kevin Chua, Martin Guimond, Veena Kapoor, Margaret Brown, Thomas A. Fleisher, Lauren Long, Donna Bernstein, Brenna J. Hill, Daniel C. Douek, Jay A. Berzofsky, Charles S. Carter, E.J. Read, Lee J. Helman, Crystal L. Mackall
Related Papers
- → Incomplete Depletion and Rapid Regeneration of Foxp3+ Regulatory T Cells Following Anti-CD25 Treatment in Malaria-Infected Mice(2007)150 cited
- Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis.(2017)
- → CD4+CD25 + Foxp3+ T-reg cells play an important role in na(i)ve immune tolerance in rat liver transplantation(2010)
- Targeting Foxp3^＋ regulatory T cells-related immunosuppression for cancer immunotherapy(2010)
- [The decreased proportion of CD4+CD25+FOXP3+ regulatory T cells in peripheral blood of children with juvenile idiopathic arthritis and its negative correlation with cytokine level].(2022)